miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer

被引:116
作者
She, Kelin [1 ,2 ]
Yan, Hui [3 ]
Huang, Jun [4 ,5 ,6 ]
Zhou, Huaping [1 ]
He, Jianxing [1 ,4 ,5 ,6 ]
机构
[1] Southern Med Univ, Guangzhou, Guangdong, Peoples R China
[2] Cent Hosp Shaoyang City, Dept Thorac Surg, Shaoyang, Hunan, Peoples R China
[3] Cent Hosp Shaoyang City, Dept Cent Lab, Shaoyang, Hunan, Peoples R China
[4] State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[5] Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China
[6] Guangzhou Med Univ, Dept Thorac Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
NONCODING RNA; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; PROLIFERATION; METASTASIS; SUPPRESSOR; MICRORNAS; APOPTOSIS; MIGRATION; INVASION;
D O I
10.1111/cpr.12406
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ObjectivesLong non-coding RNAs have identified to involve into the tumour cell proliferation, apoptosis and metastasis. We previously found that up-regulated LncRNA-SNHG7 (SNHG7) positively correlated to the Fas apoptosis inhibitory molecule 2 (FAIM2) in lung cancer cells with unclear mechanism. MethodsNon-small cell lung cancer (NSCLC) and relative normal tissues (n=25) were collected. The SNHG7 expression and function in NSCLC was determined. The SNHG7-miR 193b-FAIM2 network was analysed in vitro and vivo. ResultsWe reported that oncogene SNHG7 predicted a poor clinical outcome and functioned as competitive endogenous RNA (ceRNA) antagonized microRNA-193b (miR-193b) to up-regulate the FAIM2 level in NSCLC. Bioinformatic analysis predicted that SNHG7 harboured miR-193b-binding sites, and we found decreased miR-193b levels in NSCLC tissues when compared to relative normal tissues. Luciferase assays indicated that overexpression of miR-193b inhibited the Ruc expression of plasmid with miR-193b-binding sites of SNHG7 in a dose-dependent manner. Ectopically expressed SNHG7 also as a molecular sponge sequestered endogenous miR-193b. Besides, FAIM2 was found to be directly targeted by miR-193b. The restoration of miR-193b levels in NSCLC cell lines A549 and H125 suppressed the expression of FAIM2 and related tumour proliferation, metastasis and induced apoptosis. However, forced expression of SNHG7 could down-regulate miR-193b to elevate the FAIM2 level of tumour cells, leading to impaired miR-193b/FAIM2-induced tumour progression. Knockdown of SNHG7 in vivo significantly delayed the tumour growth with decreased tumour volume, which accompanied with enhanced miR-193b expression and reduced FAIM2 levels. ConclusionThe results indicated that miR-193b is indispensible for the ceRNA role of SNHG7 in FAIM2-supported tumourigenesis of lung cancer.
引用
收藏
页数:9
相关论文
共 28 条
[1]   Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives [J].
Antoni, Delphine ;
Mornex, Francoise .
CURRENT OPINION IN ONCOLOGY, 2016, 28 (02) :104-109
[2]   miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer [J].
Augoff, Katarzyna ;
McCue, Brian ;
Plow, Edward F. ;
Sossey-Alaoui, Khalid .
MOLECULAR CANCER, 2012, 11
[3]   MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer [J].
Chen, De ;
Dang, Bian-Li ;
Huang, Jin-zhou ;
Chen, Min ;
Wu, Di ;
Xu, Man-Li ;
Li, Rong ;
Yan, Guang-Rong .
ONCOTARGET, 2015, 6 (32) :32701-32712
[4]   The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects [J].
Ding, Liang ;
Ren, Jing ;
Zhang, Dongya ;
Li, Yi ;
Huang, Xiaofeng ;
Ji, Jianjian ;
Hu, Qingang ;
Wang, Hui ;
Ni, Yanhong ;
Hou, Yayi .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (06) :1068-1079
[5]   Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun/CCL22 signal [J].
Ding, Liang ;
Huang, Xiao-Feng ;
Dong, Guan-Jun ;
Hu, Er-Ling ;
Chen, Sheng ;
Wang, Ting-Ting ;
Hu, Qin-Gang ;
Ni, Yan-Hong ;
Hou, Ya-Yi .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (11) :2494-2503
[6]   The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling [J].
Han, Peng ;
Li, Jing-wen ;
Zhang, Bo-miao ;
Lv, Jia-chen ;
Li, Yong-min ;
Gu, Xin-yue ;
Yu, Zhi-wei ;
Jia, Yun-he ;
Bai, Xue-feng ;
Li, Li ;
Liu, Yan-long ;
Cui, Bin-bin .
MOLECULAR CANCER, 2017, 16
[7]   MicroRNAs in cancer: biomarkers, functions and therapy [J].
Hayes, Josie ;
Peruzzi, Pier Paolo ;
Lawler, Sean .
TRENDS IN MOLECULAR MEDICINE, 2014, 20 (08) :460-469
[8]   MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer [J].
Ji, P ;
Diederichs, S ;
Wang, WB ;
Böing, S ;
Metzger, R ;
Schneider, PM ;
Tidow, N ;
Brandt, B ;
Buerger, H ;
Bulk, E ;
Thomas, M ;
Berdel, WE ;
Serve, H ;
Müller-Tidow, C .
ONCOGENE, 2003, 22 (39) :8031-8041
[9]   The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs [J].
Kallen, Amanda N. ;
Zhou, Xiao-Bo ;
Xu, Jie ;
Qiao, Chong ;
Ma, Jing ;
Yan, Lei ;
Lu, Lingeng ;
Liu, Chaochun ;
Yi, Jae-Sung ;
Zhang, Haifeng ;
Min, Wang ;
Bennett, Anton M. ;
Gregory, Richard I. ;
Ding, Ye ;
Huang, Yingqun .
MOLECULAR CELL, 2013, 52 (01) :101-112
[10]   FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid [J].
Kang, Hio Chung ;
Kim, Jong In ;
Chang, Hee Kyung ;
Woodard, Gavitt ;
Choi, Young Sik ;
Ku, Ja-Lok ;
Jablons, David M. ;
Kim, Il-Jin .
SCIENTIFIC REPORTS, 2016, 6